|
Table 1: Medication use and comorbidities. |
|||
|
Variable |
SpA + EDS % |
EDS-only % |
p |
|
Biologic use |
34.8 |
7.1 |
0.05 |
|
Immunomodulator use |
73.9 |
42.8 |
0.003 |
|
NSAID use |
30.4 |
47.4 |
> 0.05 |
|
MCAS |
13.0 |
85.7 |
< 0.0001 |
|
POTS/dysautonomia |
60.9 |
78.6 |
> 0.05 |
|
IBS/digestive disorders |
60.9 |
85.7 |
> 0.05 |
|
Upper cervical instability |
17.5 |
21.4 |
> 0.05 |
|
EDS = Ehlers-Danlos syndromes. IBS = irritable bowel syndrome. MCAS = mast cell activation syndrome. NSAID = nonsteroidal anti-inflammatory drugs. POTS = postural orthostatic tachycardia syndrome. SpA = spondyloarthritis. |
|||